Mayne Pharma Group Limited
ASX:MYX.AX
4.5 (AUD) • At close September 16, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 388.399 | 183.586 | 157.147 | 400.781 | 456.985 | 525.208 | 530.313 | 572.595 | 267.28 | 140.324 | 142.181 | 82.262 | 51.078 | 48.768 | 37.044 | 1.04 | 0.821 | 0.14 |
| Kosten van de omzet
| 229.284 | 156.748 | 133.402 | 273.765 | 316.049 | 316.161 | 346.14 | 323.988 | 115.249 | 61.433 | 68.203 | 44.441 | 29.342 | 26.861 | 19.127 | 0 | 0 | 0 |
| Brutowinst
| 159.115 | 26.838 | 23.745 | 127.016 | 140.936 | 209.047 | 184.173 | 248.607 | 152.031 | 78.891 | 73.978 | 37.821 | 21.736 | 21.907 | 17.917 | 1.04 | 0.821 | 0.14 |
| Brutowinstmarge
| 0.41 | 0.146 | 0.151 | 0.317 | 0.308 | 0.398 | 0.347 | 0.434 | 0.569 | 0.562 | 0.52 | 0.46 | 0.426 | 0.449 | 0.484 | 1 | 1 | 1 |
| Onderzoek- en ontwikkelingskosten
| 20.236 | 15.729 | 12.207 | 18.91 | 21.746 | 25.805 | 12.303 | 8.275 | 8.731 | 5.588 | 4.552 | 3.985 | 4.018 | 5.974 | 5.294 | 3.146 | 2.243 | 0.823 |
| Algemene en administratieve kosten
| 0 | 58.053 | 52.945 | 50.137 | 61.826 | 81.948 | 75.951 | 78.946 | 49.77 | 28.874 | 25.576 | 15.08 | 7.257 | 6.771 | 4.488 | 2.019 | 2.05 | 1.136 |
| Verkoop- en marketingkosten
| 0 | 125.945 | 104.6 | 56.82 | 74.203 | 76.667 | 60.974 | 39.122 | 38.029 | 16.26 | 9.204 | 4.42 | 1.275 | 1.323 | 0.388 | 0 | 0.087 | 0 |
| Verkoop-, algemene en administratieve kosten
| 216.716 | 197.553 | 133.417 | 106.743 | 131.32 | 154.069 | 134.749 | 118.068 | 87.799 | 45.134 | 34.78 | 19.5 | 8.532 | 8.094 | 4.875 | 2.019 | 2.05 | 1.136 |
| Overige kosten
| 0 | 12.625 | 74.429 | 6.378 | 15.44 | -7.94 | 4.667 | 27.496 | -1.286 | 3.98 | 3.568 | -8.374 | 4.333 | 2.127 | -0.345 | 0.61 | -0.062 | 0.005 |
| Bedrijfskosten
| 236.952 | 213.282 | 145.624 | 125.653 | 153.066 | 179.874 | 147.052 | 126.343 | 96.53 | 70.023 | 50.345 | 31.885 | 17.258 | 21.606 | 15.487 | 5.165 | 4.294 | 1.964 |
| Bedrijfsresultaat
| -77.837 | -186.444 | -121.879 | 1.363 | -12.13 | 29.173 | 37.121 | 122.264 | 55.501 | 17.188 | 32.371 | 5.976 | 2.532 | -0.817 | 0.814 | -5.165 | -4.232 | -1.964 |
| Bedrijfsresultaat ratio
| -0.2 | -1.016 | -0.776 | 0.003 | -0.027 | 0.056 | 0.07 | 0.214 | 0.208 | 0.122 | 0.228 | 0.073 | 0.05 | -0.017 | 0.022 | -4.967 | -5.156 | -14.018 |
| Totaal overige inkomsten en kosten netto
| -112.25 | -83.254 | -23.708 | -265.25 | -123.237 | -382.89 | -203.908 | -6.329 | -5.664 | 2.99 | 3.562 | -8.399 | 3.301 | 0.007 | -0.345 | 0.61 | -0.062 | 0.14 |
| Inkomen voor belasting
| -190.087 | -269.698 | -145.587 | -263.887 | -135.367 | -353.717 | -166.787 | 115.935 | 49.837 | 11.243 | 28.022 | -0.703 | 7.751 | -1.504 | 0.605 | -4.125 | -3.473 | -1.824 |
| Inkomen voor belasting ratio
| -0.489 | -1.469 | -0.926 | -0.658 | -0.296 | -0.673 | -0.315 | 0.202 | 0.186 | 0.08 | 0.197 | -0.009 | 0.152 | -0.031 | 0.016 | -3.967 | -4.231 | -13.018 |
| Belastingkosten
| -21.468 | 47.745 | 74.501 | -54.805 | -40.832 | -71.629 | -32.53 | 29.909 | 15.314 | 3.706 | 6.732 | 2.14 | 1.598 | -3.183 | -2.648 | -0.364 | -0.084 | 0.135 |
| Nettowinst
| -174.233 | -316.419 | -281.286 | -208.423 | -92.789 | -279.203 | -133.984 | 88.567 | 37.355 | 7.759 | 21.29 | -2.843 | 6.153 | 1.679 | 3.253 | -3.761 | -3.473 | -1.824 |
| Nettowinstmarge
| -0.449 | -1.724 | -1.79 | -0.52 | -0.203 | -0.532 | -0.253 | 0.155 | 0.14 | 0.055 | 0.15 | -0.035 | 0.12 | 0.034 | 0.088 | -3.617 | -4.231 | -13.018 |
| WPA (Winst Per Aandeel)
| -2.19 | -3.89 | -3.46 | -2.57 | -1.14 | -3.44 | -1.65 | 1.24 | 0.95 | 0.22 | 0.69 | -0.035 | 0.58 | 0.16 | 0.38 | -0.046 | -0.043 | -0.023 |
| Verwaterde WPA
| -2.19 | -3.89 | -3.46 | -2.57 | -1.14 | -3.44 | -1.65 | 1.21 | 0.92 | 0.22 | 0.66 | -0.035 | 0.58 | 0.16 | 0.37 | -0.046 | -0.043 | -0.023 |
| EBITDA
| -9.378 | -121.003 | -66.698 | 69.551 | 72.432 | 123.67 | 117.004 | 195.932 | 76.878 | 30.69 | 42.23 | 8.998 | 12.647 | 8.526 | 7.403 | -4.125 | -3.473 | -1.824 |
| EBITDA ratio
| -0.024 | -0.659 | -0.424 | 0.174 | 0.158 | 0.235 | 0.221 | 0.342 | 0.288 | 0.219 | 0.297 | 0.109 | 0.248 | 0.175 | 0.2 | -3.967 | -4.231 | -13.018 |